Proton Pump Inhibitors: The Good, Bad, and Ugly. Review uri icon

Overview

abstract

  • Proton pump inhibitors (PPIs) continue to be the medication of choice for treatment of acid-related disease, with few if any overt side effects seen with daily use. They are often prescribed empirically, often in high doses and with many patients being treated with multiple PPIs without an objective diagnosis. Therefore, they are believed to be overprescribed and used without indication. In this article we discuss the appropriate clinical indications for PPIs, review in detail the major associated adverse events, and put in perspective key issues in balancing benefits and risk of this exceptional (and safe) class of drug.

publication date

  • January 13, 2020

Research

keywords

  • Gastroesophageal Reflux
  • Proton Pump Inhibitors

Identity

Scopus Document Identifier

  • 85080823170

Digital Object Identifier (DOI)

  • 10.1016/j.giec.2019.12.005

PubMed ID

  • 32146944

Additional Document Info

volume

  • 30

issue

  • 2